Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 169,065 | 76,057 | 501,409 | 306,267 | 464,714 |
| Marketable Securities | 433,410 | N/A | 19,031 | 59,840 | 101,547 |
| Receivables | 328,342 | 9,911 | 252,952 | 168,637 | 156,769 |
| Inventories | 91,281 | N/A | 74,864 | 64,058 | 58,329 |
| Other current assets | 44,096 | 2,121 | 34,427 | 18,907 | 0 |
| TOTAL | $1,171,085 | $94,823 | $944,381 | $666,580 | $900,696 |
| Non-Current Assets | |||||
| PPE Net | 14,534 | 13,010 | 10,409 | 10,885 | 11,258 |
| Intangibles | 55,910 | 19,790 | 56,968 | 57,501 | 58,226 |
| Other Non-Current Assets | 130,188 | 14,438 | 119,437 | 110,927 | 32,979 |
| TOTAL | $200,632 | $47,238 | $186,814 | $179,313 | $102,463 |
| Total Assets | $1,371,717 | $142,061 | $1,131,195 | $845,893 | $1,003,159 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 56,202 | 4,775 | 49,437 | 60,002 | 64,571 |
| Accrued Expenses | 457,412 | 37,160 | 350,339 | 276,630 | 268,720 |
| Other current liabilities | 62,500 | N/A | 62,500 | 62,500 | 62,500 |
| TOTAL | $576,114 | $41,935 | $462,276 | $399,132 | $395,791 |
| Non-Current Liabilities | |||||
| Long Term Debt | 634,106 | N/A | 619,267 | 274,138 | 270,756 |
| Other Non-Current Liabilities | 627,910 | 65,435 | 640,859 | 629,759 | 615,127 |
| TOTAL | $1,262,016 | $65,435 | $1,260,126 | $903,357 | $885,523 |
| Total Liabilities | $1,838,130 | $107,370 | $1,722,402 | $1,302,489 | $1,281,314 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,043 | 70,524 | 65,501 | 65,401 | 65,074 |
| Common Shares | 2,112,686 | N/A | 1,633,462 | 1,618,194 | 1,604,021 |
| Retained earnings | -2,702,154 | N/A | -2,386,572 | -2,214,756 | -2,004,137 |
| Other shareholders' equity | -6,525 | 34,691 | -3,149 | -2,439 | -1,770 |
| TOTAL | $-466,413 | $34,691 | $-591,207 | $-456,596 | $-278,155 |
| Total Liabilities And Equity | $1,371,717 | $142,061 | $1,131,195 | $845,893 | $1,003,159 |